2020
DOI: 10.7150/thno.44705
|View full text |Cite
|
Sign up to set email alerts
|

Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
172
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 263 publications
(195 citation statements)
references
References 18 publications
3
172
0
1
Order By: Relevance
“…Chen et al found b-elemene is a unique natural ferroptosis inducer. b-elemene and cetuximab, which were combined to treat KRAS mutant CRC cells, could induce ferroptosis (Chen et al, 2020). Shen et al demonstrated that RB could inactivate GPX4 to trigger ferroptosis in CRC cells, which can inhibit the growth of CRC cells and tumor formation (Shen et al, 2020).…”
Section: Colorectal Carcinomamentioning
confidence: 99%
See 3 more Smart Citations
“…Chen et al found b-elemene is a unique natural ferroptosis inducer. b-elemene and cetuximab, which were combined to treat KRAS mutant CRC cells, could induce ferroptosis (Chen et al, 2020). Shen et al demonstrated that RB could inactivate GPX4 to trigger ferroptosis in CRC cells, which can inhibit the growth of CRC cells and tumor formation (Shen et al, 2020).…”
Section: Colorectal Carcinomamentioning
confidence: 99%
“…In the experiments of Ma et al, Siramesine and lapatinib can be used synergistically to induce an increase in iron levels and trigger ferroptosis (Ma S. et al, 2017). In addition to some commonly used ferroptosis drugs, some natural compounds such as Vitamin E (Ma S. et al, 2017), Baicalein (Xie et al, 2016), b-elemene (Chen et al, 2020), gallic acid (Khorsandi et al, 2020) can regulate ferroptosis by affecting the level of lipid peroxidation. At present, one of the main methods used in tumor treatment is chemotherapy, which is mainly to inhibit the synthesis of DNA or RNA at different stages of tumor growth and spread to inhibit the abnormal proliferation of tumors.…”
Section: Othersmentioning
confidence: 99%
See 2 more Smart Citations
“…在乳腺癌中, 榄香烯通过 重塑雌激素受体α(ERα)的表达逆转乳腺癌细胞对他莫 昔芬的耐药 [54] ; 同时可通过外泌体降低耐药传递逆转 乳腺癌的多药耐药 [55] . 在大肠癌中, 榄香烯可以通过诱 导铁死亡和抑制上皮-间质转化(epithelial-mesenchymal transitions, EMT)增强KRAS突变型大肠癌对西妥昔单 抗的敏感性, 为KRAS突变型大肠癌患者的治疗提供一 种新的策略 [56] . 在神经系统肿瘤中, 榄香烯通过抑制 EGFR信号通路可增强吉非替尼对神经胶质瘤的敏感 性 [57] .…”
Section: 腺癌患者治疗效果和预后的重要因素 近几年针对乳 腺癌内分泌治疗耐药的机制研究取得较大进展 Pi3k/unclassified